Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neurobiology of Disease

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/NBDI.2001.0410PMID 11493028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior

  2004cited by this paper
• Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor.

  2000cited by this paper
• Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal System

  2000cited by this paper
• Complete and Long-Term Rescue of Lesioned Adult Motoneurons by Lentiviral-Mediated Expression of Glial Cell Line-Derived Neurotrophic Factor in the Facial Nucleus

  2000cited by this paper
• Neural transplantation for neurodegenerative disorders.

  1999cited by this paper
• Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

  1999cited by this paper
• Lentiviral gene transfer to the nonhuman primate brain.

  1999cited by this paper
• GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.

  1999cited by this paper
• GDNF Protection against 6-OHDA–Induced Reductions in Potassium-Evoked Overflow of Striatal Dopamine

  1999cited by this paper
• Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene.

  1999cited by this paper
• Other neurotrophic factors: Glial cell line‐derived neurotrophic factor (GDNF)

  1999cited by this paper
• Apoptosis in neuronal development and transplantation: role of caspases and trophic factors.

  1999cited by this paper
• GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity.

  1999cited by this paper
• Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts.

  1999cited by this paper
• A Glial Cell Line-Derived Neurotrophic Factor-Secreting Clone of the Schwann Cell Line SCTM41 Enhances Survival and Fiber Outgrowth from Embryonic Nigral Neurons Grafted to the Striatum and to the Lesioned Substantia Nigra

  1999cited by this paper
• Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse.

  1999cited by this paper
• Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants.

  1999cited by this paper
• Distribution of neurturin mRNA and immunoreactivity in the peripheral tissues of adult rats.

  1999cited by this paper
• Transplantation of Fetal Kidney Tissue Reduces Cerebral Infarction Induced by Middle Cerebral Artery Ligation

  1999cited by this paper
• Glial cell line-derived neurotrophic factor receptor α1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles

  1999cited by this paper
• Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats.

  1998cited by this paper
• Kidney cografts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery.

  1998cited by this paper
• Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates.

  1998cited by this paper
• GFR a 1 Is an Essential Receptor Component for GDNF in the Developing Nervous System and Kidney

  1998cited by this paper
• Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats

  1998cited by this paper
• Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease

  1998cited by this paper
• Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.

  1998cited by this paper
• Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.

  1997cited by this paper
• Neurturin and Glial Cell Line-Derived Neurotrophic Factor Receptor-β (GDNFR-β), Novel Proteins Related to GDNF and GDNFR-α with Specific Cellular Patterns of Expression Suggesting Roles in the Developing and Adult Nervous System and in Peripheral Organs

  1997cited by this paper
• Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex

  1997cited by this paper
• GDNF Protection against 6-OHDA: Time Dependence and Requirement for Protein Synthesis

  1997cited by this paper
• GDNF Reduces Drug-Induced Rotational Behavior after Medial Forebrain Bundle Transection by a Mechanism Not Involving Striatal Dopamine

  1997cited by this paper
• Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats.

  1997cited by this paper
• An acid-treatment method for the enhanced detection of GDNF in biological samples.

  1997cited by this paper
• Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism.

  1997cited by this paper
• An increase in intracellular levels of cyclic AMP produces trophic effects on striatal neurons developing in culture.

  1997cited by this paper
• Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts.

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Characterization of a multicomponent receptor for GDNF

  1996cited by this paper
• Differential sensitivity of dopamine release and clearance to 6-hydroxydopamine lesioning in rat striatum.

  1996cited by this paper
• Constructing a New Nigrostriatal Pathway in the Parkinsonian Model with Bridged Neural Transplantation in Substantia Nigra

  1996cited by this paper
• Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis.

  1996cited by this paper
• Neurturin, a relative of glial-cell-line-derived neurotrophic factor

  1996cited by this paper
• The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease.

  1996cited by this paper
• Excitochemical-induced trophic bridging directs axonal growth of transplanted neurons to distal target.

  1995cited by this paper
• Elevated body swing test: a new behavioral parameter for rats with 6- hydroxydopamine-induced hemiparkinsonism

  1995cited by this paper
• Cellular mechanisms involved in brain ischemia.

  1995cited by this paper
• Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo

  1995cited by this paper
• TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

  1995cited by this paper
• Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

  1995cited by this paper
• Neuron saving schemes

  1995cited by this paper
• Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

  1995cited by this paper
• Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

  1994cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• A 16-Channel Automated Rotometer System for Reliable Measurement of Turning Behavior in 6-Hydroxydopamine Lesioned and Transplanted Rats

  1993cited by this paper
• Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants

  1992cited by this paper
• Spontaneous asymmetric circling behavior in hemi-parkinsonism; a human equivalent of the lesioned-circling rodent behavior.

  1987cited by this paper
• Progress in Parkinson's disease.

  1984cited by this paper
• Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.

  1982cited by this paper
• Striatal efferent fibers play a role in maintaining rotational behavior in the rat

  1977cited by this paper
• Parkinson's disease: from brain homogenate to treatment.

  1973cited by this paper
• Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

  1971cited by this paper
• Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

  1970cited by this paper

• NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats.

  2019cites this paper
• An update on the use of melatonin as a stroke therapeutic.

  2015cites this paper
• Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

  2015cites this paper
• Delta Opioid Receptor and Peptide: Hibernation for Stroke Therapy

  2015cites this paper
• Effects of aging on glutamate neurotransmission in the substantia nigra of Gdnf heterozygous mice.

  2015cites this paper
• ESTROGEN REPLACEMENT THERAPY FOR STROKE.

  2014cites this paper
• Delta Opioid Receptor and Its Peptide: A Receptor-Ligand Neuroprotection

  2013cites this paper
• Melatonin-Based Therapeutics for Neuroprotection in Stroke

  2013cites this paper
• Stem cell-based therapies in Parkinson’s disease: future hope or current treatment option?

  2011cites this paper
• Restoration of Nigrostriatal Pathway in Parkinson's Animals by the Bridge Transplantation Technique

  2009cites this paper
• Hibernation-like state induced by an opioid peptide protects against experimental stroke

  2009cites this paper
• The nigrostriatal dopamine system of aging GFRα‐1 heterozygous mice: neurochemistry, morphology and behavior

  2008cites this paper
• Transplantation of Fetal Kidney Cells: Neuroprotection and Neuroregeneration

  2005cites this paper
• Characterization of the dopaminergic potential of the human ntera2/d1 (nt2) cell line in vitro

  2005cites this paper
• Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach.

  2005cites this paper
• Central Nervous System Entry of Peripherally Injected Umbilical Cord Blood Cells Is Not Required for Neuroprotection in Stroke

  2004cites this paper
• Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier.

  2004cites this paper
• Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system

  2004cites this paper
• Intracerebral Xenotransplantation of GFP Mouse Bone Marrow Stromal Cells in Intact and Stroke Rat Brain: Graft Survival and Immunologic Response

  2004cites this paper
• Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.

  2004cites this paper
• Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats.

  2004cites this paper
• Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion.

  2004cites this paper
• Melatonin-Secreting Pineal Gland: A Novel Tissue Source for Neural Transplantation Therapy in Stroke

  2003cites this paper
• [Stem cells: solution to the problem of transplants in Parkinson's disease?].

  2003cites this paper
• Effect of glial cell line‐derived neurotrophic factor (GDNF) co‐transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6‐hydroxydopamine (6‐OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies

  2003cites this paper
• Neural transplantation for treatment of Parkinson's disease.

  2002cites this paper
• Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats.

  2002cites this paper
• Protective Effects of Glial Cell Line‐Derived Neurotrophic Factor in Ischemic Brain Injury

  2002cites this paper